À propos de ce podcast
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech. Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences. Produced by OWITH.ai, a boutique AI & data studio. Sponsor the show: https://sponsor.owith.ai
63 épisodes · Technisch nieuws
Pharma and BioTech Daily
À propos de ce podcast
Pharma & Biotech Daily is a short, AI-generated, human-supervised briefing on what’s important in pharma and biotech. Each weekday we condense key news on pipelines, deals, regulation and strategy into a quick audio update for people who build, run and invest in life sciences. Produced by OWITH.ai, a boutique AI & data studio. Sponsor the show: https://sponsor.owith.ai
Épisodes récents
- GSK Invests $800M in Biologics Facility | Pharma and Biotech DailyNouveau · 5 min
- Asahi Kasei's $920M AiCuris Buy Leads to FDA OK | Pharma and Biotech Dailyavant-hier · 5 min
- GSK AI Partnership & Roche's FDA Win: $117M IPO Buzz | Pharma and Biotech Dailyil y a 3 jours · 5 min
- Novartis' Rhapsido FDA Expansion Boosts Revenue Potential | Pharma and Biotech Dailyil y a 6 jours · 5 min
- Cerevance's Solengepras Hits Phase 3 Success for Parkinson's | Pharma and Biotech Daily8 oct. · 5 min
- Shionogi Acquires Intrabio for $2B: Rare Disease Focus | Pharma and Biotech Daily7 oct. · 5 min
- Bayer's $2.2B Ohio Site Boosts U.S. Pharma | Pharma and Biotech Daily6 oct. · 5 min
- Novartis's $7.8B mRNA Deal with Abogen | Pharma and Biotech Daily5 oct. · 5 min
- Sanofi's $1B Deal with Regeneron: Immunology Breakthroughs | Pharma and Biotech Daily2 oct. · 4 min
- Eli Lilly's Retatrutide: 25% Weight Loss in Phase 3 Trial! | Pharma and Biotech Daily1 oct. · 6 min
podlinkr.com/fr/pharma-and-biotech-daily
Pour une affiche ou une diapo.